Human Nutrition Market Size

Global Human Nutrition Market size was valued at USD 396.2 billion in 2023 and is poised to grow from USD 421.56 billion in 2024 to USD 692.45 billion by 2032, growing at a CAGR of 6.4% during the forecast period (2025-2032).

The global human nutrition market is highly competitive and consists of several big players and small to medium size companies penetrating the market. The market penetration for new entrants is high due to the presence of less stringent regulations and availability of various D2C channels such as Social media (Instagram, Facebook, among others), B2C websites (Amazon, Walmart, among others). The availability of a variety of products in the market has offered consumers a wide range of options to choose from based on their needs, allowing them to evaluate nutritional benefits and costs. Additionally, the growth of e-commerce and online shopping has encouraged consumers to purchase goods online. Hence, the bargaining power of buyers is medium to high. 'Nestlé S.A. (Switzerland) ', 'Danone S.A. (France) ', 'Abbott Laboratories (USA) ', 'PepsiCo, Inc. (USA) ', 'Unilever PLC (UK/Netherlands) ', 'The Coca-Cola Company (USA) ', 'Pfizer Inc. (USA) ', 'Herbalife Nutrition Ltd. (USA) ', 'Amway (USA) ', 'Nature's Bounty Co. (USA) ', 'GNC Holdings, LLC (USA) ', 'Pharmavite LLC (USA) ', 'NOW Foods (USA) ', 'Glanbia plc (Ireland) ', 'Nutrabolt (USA) ', 'Fresenius SE & Co. KGaA (Germany) ', 'Baxter International Inc. (USA) ', 'Kerry Group plc (Ireland) ', 'DSM (Netherlands) ', 'Bayer AG (Germany)'

The rise of a high-income middle class in emerging markets is expected to drive the growth of the global human nutrition market. By the end of 2018, there were 679 million middle-class households in emerging countries, a figure that is expected to expand by 2.7% by 2030. In comparison, the number of middle-class households in developed countries was 176 million in 2018 and is expected to increase by 6.3% by 2030. Between 2019 and 2030, the number of households in developing countries with an annual disposable income of USD45,000-100,000 Purchasing power parity (PPP) is expected to rise by 5.6% per year on average, far outpacing the 1.2% annual growth expected for the total number of households. Their spending is expected to rise at a 6.9% annual rate in real terms through 2030, outpacing the 1.9% annual real spending growth forecast for households earning USD15,000-45000 (PPP).

Global rise in the incidence and prevalence rate of chronic diseases and increasing healthcare cost created significant awareness for the human nutrition market. Chronic diseases such as heart disease, cancer, diabetes, stroke, and arthritis have been on the rise, in recent times; which significantly creates a wide scope for the market growth.

In 2021, North America held the notable global human nutrition market share and is anticipated to continue its dominance. This can be attributed to the United States being the market's epicenter attributed to the prevalence of a well-developed distribution channel as well as the production hub of key manufacturers. Furthermore, the increasing demand for such dietary supplements across countries is one of the factors driving market growth in North America. However, Asia-Pacific is expected to be the fastest-growing market during the forecast period, owing to rising consumer bases in the region's countries such as India, China, and South Korea. Furthermore, consumers in the regions are increasing their expenditure due to the increase in per capita income, which is anticipated to accelerate market growth during the forecast period.